Quick Answer
GE HealthCare Technologies Inc. reported Research And Development Expense of $1.26 billion for the year ending 2025.
- GE HealthCare Technologies Inc. showed a decrease of -3.9% in Research And Development Expense from 2024 to 2025.
- This data is from GE HealthCare Technologies Inc.'s annual report (Form 10-K), filed with the SEC on February 4, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), GE HealthCare Technologies Inc.'s Research And Development Expense has grown by 54.4%.
- Historical annual values: Fiscal year 2025: $1.26 billion | Fiscal year 2024: $1.31 billion | Fiscal year 2023: $1.21 billion | Fiscal year 2022: $1.03 billion | Fiscal year 2021: $816.00 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: